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Various theories of antibody formation (1, 2, 3) propose that the primary antigenic 
stimulus is mediated by preformed specific "natural" antibody molecules. 
A large amount of data has now accumulated (4--10) indicating that passively ad- 
ministered specific antibody has a  depressive effect on the immune response. Both 
preparations of 7S antibody and, to a lesser degree, preparations of 19S antibody were 
found to be depressive.  It has been proposed (4)  that the antibody acts directly on 
antigen-sensitive target ceils, but the evidence now suggests that antibody inhibits 
the response by combining with antigenic determinants. Recently, it has been found 
(11) that when two hapteus are present on one carrier molecule, suppression of anti- 
body formation against one determinant does not necessarily suppress antibody forma- 
tion against the second determinant.  It therefore appears that suppression of the 
response by antibody does not imply a prevention of the antigen from reaching the 
target  area.  Possibly, binding  of  antigenic  determinants  by  antibody reduces  the 
number of free determinants available for stimulation. 
Though apparently contradicted by these findings,  the theories alluded  to in the 
first paragraph, do not lack experimental support. Segre and Kaeberie (12) found that 
both specific antibody and "normal" gamma globulin  enhance the antibody response 
of newborn piglets deprived of colostmm. I-Iemphill et al. (13) terminated tolerance to 
human serum albumin in mice by injecting antigen-antibody complexes.  M/iller  and 
Wigzell  (7)  found a  minor enhancement of the number of plaque-forming cells  in 
occasional mice when small amounts of specific antibody were administered prior to 
an injection of sheep red  cells.  Williams  (14) has  demonstrated  that  the  reduced 
follicular  localization of polymerized flagellin observed in X-irradiated and lympho- 
cyte-depleted rats  was significantly  improved when specific  antisera were injected 
prior to antigen injection. In these studies, the immunoglobulin type of the enhancing 
antibody was not determined. More recently, Pearlman (15) has reported that whereas 
both 19S and 7S antibodies are effective inhibitors of antibody formation, both are also 
capable of enhancement when given in small amounts. In contrast to the depressive 
effect,  enhancement appeared to be nonspecific.  Others have reported that,  though 
small amounts of IgG anti-Rh antibody can suppress the response of Rh-negative 
mothers to the Rh-positive ceils of their newborn, relatively small amounts of IgM 
antibody actually result in enhanced antibody formation (16). 
The  present  studies  were  initiated  in  the  hope  of  clarifying  some  of  the 
questions  raised by our  studies  of the  primary immune response  of mice to 
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different  doses  oI  red  cells. 1, :  Preliminary  experiments  I  had  indicated  that, 
although  small  amounts  of specific 7S  antibody  were  suppressive  when  given 
prior  to antigen,  equal molar amounts  of  19S antibody  consistently  enhanced 
the  primary  immune  response.  The  result  of  antigenic  stimulation  after  the 
administration of 7S and 19S antibody appeared to depend on the ratio of these 
two  species  of immunoglobulin.  We now present  additional  quantitative  data 
substantiating  this claim. An abridged account of some of our findings has been 
reported  (17). 
Materials and Methods 
Animals.--Most  of the data were obtained with inbred NMRI mice aged 6-8 wk. In pre- 
liminary experiments, AKR mice of the same age were used. We have observed no difference 
in the response of these two strains. Because of the wide variation in the responses of individual 
animals, large numbers of mice must be used to establish an average response with a sufficient 
degree of confidence.  Each experimental point in this paper represents the arithmetic mean of 
the number of plaque-forming cells  (PFC)  per spleen obtained  in a  group  of  10-50  mice. 
The Agar Plaque Teehnique.--This method was used to detect individual antibody produc- 
ing cells (PFC's) has previously been described in detail (18, 19). 
Serological 2~rocedures.--ttemolysin titers were determined by tube titrations except when 
we had only small quantifies of sera available and wished to determine the content of both 
7S and 19S hemolysins. Plate titrations adapted from the plaque method used to distinguish 
between cells producing 19S and 7S antibodies (19) were then done, using very small quantities 
and circumventing dialysis procedures. For each serum, four "Optilux" Petri dishes (Falcon 
Plastics, Los Angeles,  Calif.) were supplied with a  thin layer of 2 mi of 0.7% Difco agar in 
Eagle's solution containing 1 mg DEAE dextran and 4 X  l0  s sheep red cells (SRC). Volumes 
of 0.005  ml of undiluted serum and serial two-fold dilutions were dropped from a Carlsberg 
pipette onto each plate. After 30 rain of incubation at 37°C, 4 ml of 0.15 M 2-mercaptoethanol 
(ME) were added  to two plates, the remaining two receiving 4 mi of Eagle's solution. The 
plates were incubated  1 hr, then extensively washed to remove all trace of ME. To one con- 
trol and one ME-treated plate, 1.5 ml of rabbit antiserum to mousegamma globulin were then 
added. 30 min later, all four plates received 1.5 ml of complement and were incubated for a 
further 30 rain.  Reading areas showing total or partial lysis as positive, the titers obtained by 
this method agreed very well with those of the conventional tube method. The titer of a pure 
7S preparation,  developed in the presence of anti-mouse gamma globulin (indirect titer) was 
about 300-fold  higher than that obtained in its absence  (direct titer)  and the titer was un- 
affected by treatment with ME. The same degree of potentiation by rabbit anti-mouse gamma 
globulin was observed in tube titrations. As shown by Humphrey and Dourmashk;n  (20, 21) 
a single antibody molecule attached to a sheep red cell can activate complement to produce 
lysis, whereas 500-1000 molecules of 7S antibody must be present on one sheep red cell before 
lysis occurs.  To permit comparison on a molar basis of the effects of 7S and 19S preparations, 
we have defined the concentration of 19S antibody as the direct hemolytic titer of a 19S prep- 
aration and the concentration of 7S antibody as 1000 times the direct hemolytic titer of a 7S 
preparation. 
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Preparation of Antibody Fractions.-- 
78: Serum rich in specific 7S antibody of high avidity was obtained from mice hyperim- 
munized by three courses of triweekly intraperitoneal  injections of 4 X  l0  s SRC, allowing 
7-10 days of rest between each course of injections. The animals were bled 10 days after the 
last injection. The gamma globulin was precipitated  by ammonium sulfate and the excess 
salt removed by passage through a short column of Sephadex G-25. Good separation of 7S 
and 195 components was achieved when 0.3 mi was layered onto 4.5 ml of a preformed linear 
gradient of sucrose (ranging from 0.3--0.7 g) and centrifuged at 35,000 rpm in a SW39 rotor 
for 14 hr. Two fractions were harvested from each tube, and four runs gave us a pool of about 
7 ml. Two such preparations were used in the experiments reported in this paper. 
195: Mice were immunized with a single intravenous injection of 4 X  10  s SRC and bled 5 
days later when the serum had its maximal titer of 195 antibody together with a significant 
amount of early 75 antibody.  Three  techniques were applied to isolate the macroglobulin 
fraction. Six 195 preparations were obtained by sucrose gradient centrlfugation as described 
above. One preparation was obtained by Pevikon block electrophoresis followed by gel filtra- 
tion on a long colunm of Sephadex G-200 (22). Nine preparations were made by euglobulin 
precipitation at pH 5.5 after the addition of 10 volumes of distilled water and storage overnight 
at 4°C. The precipitate was washed twice, resuspended in saline to approximately half the 
initial volume, and daxified by centrifugation at 3000 g for 30 rain. The protein concentration 
of our nine euglobulin preparations, determined initially  by a modified Folin method (23) and 
t~  subsequently by absorbancy at 280 m~ (El om was calculated to be 17.5), ranged from 2-9 
mg/ml. The corresponding hemolytic titers varied from 2560 to 7680. We found euglobulin to 
be the most convenient source of large amounts of relatively pure high titer 195 antibody. The 
question of contamination of the 195 preparations with specific 75 antibody will be discussed 
later. 
Unless otherwise indicated, the mice producing the antibody and the recipient mice were 
of the same inbred strain, and the antibody fractions were given intravenously in a 0.1 ml 
volume 1-2 hr prior to the intravenous injection of SRC. 
RESULTS 
Experiments with 7S Antibody 
Time of Administration of 7S Antibody.--Fig.  1 shows the PFC response of 
mice which had  received 0.1  ml of  a  7S  preparation  (direct lyric titer  320) 
before or after a single injection of 4  X  107 sheep red cells (SRC). The features 
displayed by this figure are in accordance with the findings reported by MSller 
and Wigzell (7). When the 7S antibody was given to mice in which the immune 
response had already been initiated by SRC  given 1 day earlier, there was a 
delay of more than 24 hr before any inhibitory effect could be observed. 
When 7S antibody is administered before the SRC, the suppression is mark- 
ediy greater than when it is given 4 hr after the SRC. At that time, the SRC 
have  already  localized in  the  spleen.  8 Assuming that  the  antibody acts  by 
combining with antigenic determinants, it would appear that either the antigen 
a Koros, A. M. C. 1965. A study of the primary immune  response, employing the technique 
of plaque formation in agar by single antibody-producing ceils. Ph.D. dissertation. University 
of Pittsburgh School of Medicine. Dissertation Abstr. 26: 3385. 136  REGULATION  OF  P~Y  IMMUNE  RESPONSE 
has  become protected against  the  effect of passively administered  antibody 
within a few hours after SRC injection, or that the antigen has partly completed 
its role in the stimulus within that time period. The latter possibility would 
imply that antigenic stimulat/on is not needed for a  continued rise in PFC in 
the spleen. 
The  direct  titer  of  the  passively  introduced  7S  antibody  in  these  mice, 
assuming a  1:20 dilution  in  the blood,  would be  16,  a  level never found in 
normal, untreated mice. Higher concentrations of 7S antibody would therefore 
appear to have no relevance for the early normal primary response, though ex- 
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F:m. 1. Inhibition of the primary response of mice to a single intravenous injection of 4  X 
107 SRC by 0.1 ml of 7S anti-SRC antibody of direct hemolytic titer 320, given intravenously. 
A, 1 hr before SRC; O, 4 hr after SRC; A, 1 day after SRC; ", 2 days after SRC. Controls, 
(D, received no antibody.  Each point is the mean number of PFC per spleen of 10 mice. 
periments with 7S preparations of high titers have yielded important informa- 
tion on the regulatory role of 7S antibody in later stages of the immune response 
(7,  10).  In order to determine whether or not 7S  antibody could play a  role 
in  the  initiation  of  the  normal  primary  response,  we  therefore looked  for 
conditions in which small amounts of 7S antibody were effective. 
The distribution of PFC per spleen among individuals of a group of normal 
mice  can  be  described  as  negative  binomial,  2 a  distribution  that  can  arise CLAUDIA  HENRY  AND  NIELS  K.  JERNE  137 
under a birth and death model in which the probabilities of arrival, birth, and 
departure of cells are constant (24). As the birth process in untreated animals 
might result from a mechanism similar to that following a small dose of antigen, 
we tried to establish whether the maintenance of low levels of 7S antibody over 
an extended period might prevent the appearance of new clones of "normal" 
PFC in mice in the absence of antigen. 
Over a 3 wk period, 30 AKR mice each received nine intravenous injections 
of 0.1-0.2 ml of a  7S preparation diluted to a  direct hemolytic titer of 3.  As- 
suming  a  half-life of 4  days for isologous  7S  immunoglobulin,  the  times  of 
TABLE I 
E.~ect of the Time of Administration  of 7S Antibody on the Response  of Mice to 4  X  l0  s SRC 
Experimental group  Direct hemolytic titer of 7S preparation  PFC per spleen 
A 
B 
C 
D 
E 
(6) 
12 
40 
12 
40 
12 
40 
10,000 
320 
1,400 
1,000 
4,300 
2,400 
4,200 
1,600 
Group A received antigen alone. Group B received multiple injections of minute amounts 
of 7S antibody over a 3 wk period in an attempt to maintain, in the circulating blood, an anti- 
body level equivalent to that resulting from a single injection of a 7S preparation of a direct 
hemolytic titer of 6, as described in the text. Group C received 7S antibody 1 day, and group 
D  1 hr prior to antigen. Group E received antibody antigen complexes. All responses were 
determined 3 days alter the injection of SRC. 
injection  were spaced so that  the  titer  of  7S  antibody in  the  serum  of the 
frequently injected mice would be maintained at a level similar to that produced 
just after a single injection of 0.1 ml of a  7S preparation of a  direct lyric titer 
of 6. The circulatory concentration of 7S antibody introduced by such a single 
injection is detectable only by an indirect titration, but is sutticient to com- 
pletely suppress the response to 4  X  106 SRC. The mean number of normal 
PFC per spleen of 20 of the frequently injected mice at the end of the 3 wk 
period was  103.  In a  control  group  assayed simultaneously,  it was 47.  The 
difference is probably negligible as the value  for  the  control group is abnor- 
maUy low.  (On  the average we find 80 normal PFC per  spleen).  There was 
obviously no depression  of the level of normal PFC.  It is possible that  the 138  REGULATION  OF  PRIMARY  T~UN~  RESPONSE 
spontaneous birth and death rates of PFC in untreated mice are too low for an 
effect to be manifest within 3  wk. 
When  the  remaining  10  mice  of  the  treated  group  were  challenged  with 
4 X  los SRC and sacrificed 3 days later, they showed a mean response of only 
320 PFC per spleen. An untreated control group receiving 4 ×  1@ SRC at the 
same time gave a  mean response of 10,000  PFC. In  Table I, this surprisingly 
high degree of suppression exhibited by these mice (group B) is compared with 
the effect of low concentrations of 7S antibody given in a  single injection of 
0.1 ml at various times before an injection of 4  ×  108 SRC.  Group E  in this 
table received 0.1  ml of washed complexes of 4  X  l0  s SRC  and the indicated 
amount of specific 7S antibody.  Each value in the last column gives the re- 
sponse at 3 days after the injection of SRC and represents the mean of 10--20 
animals. The similarity in behavior of groups D  and E  suggests that when 7S 
antibody is  injected shortly before antigen,  the  attachment  of antibody  to 
antigen occurs in the circulation. A more effective site of action must be invoked 
to explain  the  greater suppression  observed when  antibody is given earlier. 
Since it  appears  that  antigenic  stimulation  takes  place  in  the  spleen  when 
antigen is given intravenously (25), it is possible that antibody can accumulate 
in  crucial  splenic  sites.  The  magnitude  of  the  suppression  observed after 
minute amounts  of 7S  antibody had been administered  over a  3  wk period 
(group B)  could either be ascribed  to accumulation of antibody in effective 
histological positions or to suppression of the emergence of antigen-sensitive 
target cells. 
Variation of the. Dose of SRC, for a Given Dose of 7S Antibody.--To investigate 
the inhibitory effect of a given concentration of 7S antibody on the response of 
mice to various doses of SRC, we selected a concentration which would have a 
measurable effect on a  great range of antigen doses. Prdiminary experiments 
suggested that a 7S preparation diluted to a titer of 8 by direct hemolytic test 
would be suitable for this purpose. A volume of 0.1 ml of this preparation was 
injected 1-2 hr before SRC. 
Fig. 2 shows the increase with time of the mean PFC per spleen of groups of 
mice which had received a single injection of 4 ×  10  7, 4 X  10  6, or 4 ×  10  5 SRC. 
The response of the antibody-treated group given 4 X  10  7 SRC is very similar 
to that of the normal controls given 4 X  10  6 SRC, that of the antibody-treated 
group given 4  X  10  6 SRC similar to that of the controls given 4  X  10  6 SRC 
and  the low response of the  antibody-treated group given 4  X  10  5 SRC  is 
similar to the normal response to 4 X  10  4 SRC. It thus appears that, at all SRC 
doses, the interaction of this concentration of 7S antibody with the sheep red 
cells, leaves about 10 % of the determinant groups effective. This concentration 
of 7S antibody failed to reduce the response to 4  X  l0  s SRC  which is com- 
patible  with  this  conclusion,  since  there is  no  perceptible difference in  the 
response of normal mice injected with 4 X  l0  s or 4 >( 10  7 SRC. Apparently, the CLAUDIA IIENRY AND NIELS K. JERNE  139 
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antibody, even in this low concentration, is not exhausted by antigen in the 
dose range used. The curves denoted 19S in Fig. 2 will be discussed in a later 
section. 
Variation  in the Dose of 7S Antibody, for a Given Dose of SRC.--We have 
studied the effect of a single intravenous injection of different dilutions of a 7S 
antibody preparation (direct hemolytic titer 480) on the response  of mice to 
4 X  105 SRC. The mice received an injection of 0.1 ml antibody 1-2 hr before 
antigen, and the number of PFC's per spleen was  determined  6  days  later. 
Untreated mice injected with 4  )<  105  SRC exhibit a maximum of PFC per 
spleen at this time.  The average response at 6 days of 200 control mice that 
received 4 )<  105 SRC was 4000 PFC per spleen. This normal response level is 
represented by a horizontal line in Fig. 3. The abscissa indicates,  on a loga- 
rithmic scale, the concentration of passively introduced antibody in the mice, 
which for 7S has been calculated as 1000 T/20 where T is the direct hemolytic 
titer of the injected preparation, and a dilution of 1:20 in the blood after an 
intravenous injection of 0.1 ml is assumed. 
The lower part of Fig. 3 shows the depressive effect of passive 7S antibody. 
Each solid circle is the mean number of PFC per spleen of a group  of 20-50 
mice 6 days after receiving 4 )< 105 SRC preceded by specific 7S antibody. On 
the  logarithmic scales  shown  here,  the magnitude of  the  depression  of the 
response  appears  to  increase  linearly with  the  7S  antibody concentration. 
Mice given higher concentrations of 7S antibody than those included in Fig. 3 
did not respond to 4 X  105 SRC, whereas those given a dilution of more than 
1:3000  of  the  7S  preparation  produced  a  normal  response  level.  The  line 
drawn through the points has a slope of about one, so that the degree of 7S 
depression is approximately proportional to the concentration of 7S antibody. 
Experiments with 19S Antibody 
Variation in the Dose of 19S Antibody, for a Given Dose of SRC.--The upper 
part of Fig. 3 shows the response at 6 days of mice which received specific 19S 
antibodies 1-2 hr prior to an injection of 4 X  105 SRC. The open circles repre- 
sent  the  responses  of the groups  of mice that received  either undiluted or 
diluted  euglobulin  preparations.  Responses  of  animals  injected  with  19S 
preparations obtained by density gradient centrifugation or by block electro- 
phoresis -1-  Sephadex  G-200 are given by the triangles  and the square respec- 
tively. The latter point has been encircled in Fig. 3, together with two points 
representing euglobulin preparations that were found, on a molar scale, to be 
contaminated, by about 50%,  with early 7S antibody. The concentration of 
passively introduced 19S antibody in the mice is shown on the abscissa, cal- 
culated as T/20, where T is the hemolytic titer. 
It will be seen that, in contrast to 7S, specific 19S anti-SRC-antibody in a 
wide range of concentration enhances the immune response to SRC, and that CLAUDIA HENRY AND NIELS K.  fERlCE  141 
the  degree  d  enhancement  increases  linearly  with  the  19S  concentration.  A 
line with a  slope of 0.5 has been drawn through the points, showing that the 
degree of 19S enhancement is approximately proportional to the square root of 
the 19S antibody concentration. 
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Fig. 3. Elevation by specific 19S antibody, and depression by specific 7S antibody, o( the 
primary immune response of mice to a single intravenous injection of 4 X 105 SRC as measured 
by the number of PFC per total spleen 6 days later. The antibody was injected intravenously 
in 0.I ml 1-2 hr before the SRC. The relative molar concentration  of specific antibody was 
calculated from the hemolytic titer as explained in the text. The open symbols represent the 
average responses of groups of mice that received 19S antibody, the solid circles represent the 
average responses of groups that received  7S antibody.  Each point is the mean number of 
PFC per spleen of 20-50 mice after deduction of the number of normal PFC sho~. 
When both curves in Fig.  3  are extrapolated  to the normal response level, 
they denote antibody concentrations that may well be present  in our normal 
mice. We have, in fact, found the hemolytic 19S antibody titers present in our 
untreated mice to range from 0-16, with a mean of 4.3. We have not, however, 
been  able  to  detect  antibodies  of  the  7S  class,  neither  after  elimination  of 142  REGULATION  OF PRIMARY ~UNE  RESPONSE 
ME-susceptible  antibodies,  nor  by  searching  for  hemolytic  activity  in  the 
normal  7S  globulins  obtained  by  sucrose  gradient  centrifugation  of  pooled 
normal mouse sera. As the potentiation of the hemolytic titer afforded by our 
rabbit  anti-mouse gamma globulin  in indirect titrations is  about 300 rather 
than  1000,  the 7S extrapolation value of Fig. 3 would be just at our limit of 
detection.  Since  evidence  already  presented  above  suggests  that  continued 
presence in the circulation may cause 7S antibody to be concentrated in critical 
locations, our failure to detect 7S hemolysins in the serum may not exclude a 
role for 7S antibody in  the primary response.  However, the PFC in normal 
mouse spleens seem to be mainly, if not exclusively, cells secreting 19S  anti- 
bodies.  4 
It does not appear that the preexisting level of circulating 19S hemolysins 
is the only factor determining the response of an individual mouse to a  SRC 
stimulus. If that were so, we would expect that the variation in response among 
mice which were passively given a  high concentration of 19S hemolysin prior 
to 4  X  l0  s SRC would be less than  that among untreated mice which received 
this dose of SRC. This has not  been observed. Furthermore, we have found 
hardly any correlation between the level of  19S hemolysin determined in in- 
dividual mice before injection of 4  X  105 SRC, and the response 6 days later. 
An obvious cause of the variability would be differences in the number of target 
cells present in individual mice. We have not discarded the idea, however, that 
variation in the level of preexisting specific 7S antibody may also be important. 
Variations  in the Time of Sacrifice and the Dose of SRC.--The enhancement 
by 19S antibody of the response to 4 X  105 SRC reported above was observed 
at 6 days after the antigen injection, the day when normal mice injected with 
this dose attain their peak level of PFC per spleen. Since the time/log response 
curves of mice not given passive antibody have decreasing slopes for decreasing 
antigen doses,  we determined the time/log response curves of mice that had 
received specific 19S  antibodies prior to antigen.  Fig.  2 includes such curves 
for mice which were given 0.1 ml of a  19S  preparation 1-2 hr  before 4  X  105 
or 4  X  l0  s SRC. There were 10-20 mice in each group, as well as in the cor- 
responding control group sacrificed on the same day. The enhancing effect was 
not apparent during the first 3 days of the response and the 19S antibody did 
not appear to affect the time at which the peak response to 4 X  105 SRC was 
attained.  Less  extensive  experimental results  with  other  SRC  doses  are  in 
accord  with  these  findings. 
Mice given 19S antibody and 4 X  10  n SRC may, at the peak of the response, 
exhibit as many PFC per spleen as untreated mice given 4 X  10  ~ SRC, but Fig. 2 
shows the time  curves to be markedly different. A  possible interpretation is 
4  Fuji, H., and N. K. Jerne. The kinetics  of the appearance  of I9S and 7S antibody-releasing 
cells in the primary immune response. Manuscript in preparation. CLAUDIA  HENRY  AND  NIELS  K.  fERN'E  143 
that the response (as  measured by PFC) of eugiobulin-treated  mice as well as 
untreated mice is similar during the first 3 days, after which the rate of increase 
of PFC diminishes in untreated mice but is maintained in the treated mice. 
It could be imagined that attachment of more 19S antibody to the red cells 
permits them to exert an initial stimulus sufficient to maintain a maximal rate 
of cell division for a  longer  time.  Alternatively, if an initial stimulus is not 
suffieient to maintain cellular  proliferation,  the  19S-coated  SRC  may be so 
placed that it can more efficiently stimulate the progeny of the ceils initially 
stimulated. 
It can also be noted from Fig. 2 that the effect of a given dose of specific 19S 
antibody is less marked for the response to 4 X  10  ~ SRC than to 4 X  106 SRC. 
We have investigated the degree of enhancement afforded by one 19S antibody 
preparation over the antigen range of 4  X  104  to 4  X  106  SRC.  The mice 
received the 19S antibody 1-2 hr before the SRC, and they were killed when 
they had presumably attained their peak level of PFC, i.e.,  5 days later for 
the doses 2 X  106 and 4 X 106 SRC, 6 days for 2 X  10  s, 4 X  105, and 106 SRC, 
and 8 days for 4 X  104 and 10  t SRC. Each control and treated group contained 
10 animals. Fig. 4 illustrates that the degree of elevation is considerable for the 
lower doses and tapers off towards high doses of SRC.  This 19S preparation 
showed no effect on the response to 4 X  10  ~ SRC's. A two-fold elevation of the 
response to this latter dose, has, however, been observed with a more potent 
19S preparation, which enhanced the response to 4 X  105 SRC 15-fold and that 
to 4 X  106 SRC five-fold. It could be imagined that the enhancement by 19S 
antibody is less marked at high SRC doses because  of competition with the 
considerable  amounts of 19S (and 7S)  antibody produced by the responding 
cells. 
Identification of the Enkancing Substance.--In the previous sections, we have 
assumed that enhancement of the response was caused by specific 19S antibody. 
There are several justifications for this assumption. 
Fig.  3  shows  that  the degree  of  enhancement increases  with the specific 
hemolytic titer of the 19S preparation. In addition, it indicates that the en- 
hancive properties  of preparations obtained by three independent methods of 
fractionation are similar. The final product obtained by all methods contained 
the bulk of the hemolytic activity of mouse serum 5 days after a large dose of 
SRC.  Sucrose gradient centrifugation selected  the macroglobulins.  The frac- 
tion  of  serum  obtained  after preparative  zone  electrophoresis  followed  by 
Sephadex G-200 filtration was the high molecular weight fraction of the com- 
ponents migrating in the region  included by the faster part  of the gamma 
globulin and the slower part of the beta globulin. A characterization of the 
euglobulin  precipitate is more  difficult.  Human euglobulin  usually contains 
IgM, low density lipeproteins,  ceruloplasmin, beta-lC globulin, and a portion 
of the IgG, the composition being dependent on both pH and the ionic strength 144  R]~GLrLATIOI~/ 0]~ PRIMARY  rMMUIW~ RESPONSE 
of the medium (26). The last three components of the precipitate would, on a 
molecular weight basis, be selected against by the other two methods of prepa- 
ration. IgM therefore seems to be the only component present in large amounts 
in all three types of preparation. 
We have confirmed the specificity of the 19S activity. Preparations from the 
pooled sera of normal mice obtained  either by sucrose gradient centrifugation 
or by euglobulin precipitation did not influence the normal response to 4 ×  106 
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SRC.  We have  also  investigated  the  effect of euglobulin  preparations  con- 
taining 19S hemolytic antibody against SRC on the response of mice to chicken 
and  ox  red  cells.  An  anti-SRC  euglobulin  preparation  which  enhanced  the 
response of mice to 4 X  105 SRC  10-fold was without effect on the response of 
mice  to  chicken  red  cells,  and  only marginally  effective in  enhancing  the 
response of mice to ox red cells.  (We observed 15 % and 38 % enhancement in 
two experiments each of which included 20 mice injected with ox red ceils.) 
Chicken red cells and SRC cross-react to a negligible degree in mice. Spleens 
of mice that had been injected with  ox red cells show about six times more CLAUDIA HENRY  AND  NIELS  K.  JERNE  145 
plaques when plated on ox red cells than when plated on SRC. In the converse 
situation, the number of plaques on SRC plates is  15 times that on ox red cell 
plates. 
Are specific macroglobulins raised in animals of a different species effective 
in enhancing the primary response of mice? Any mechanism involving attach- 
ment of either free 19S or antigen-19S  complexes  to cellular  receptors might 
require the 19S antibody to be homologous.  If enhancement were the conse- 
quence of combination between specific macroglobulins and  antigenic  deter- 
minants, both homologous and heterologous preparations might  enhance.  Eu- 
globulins  obtained from NMRI mice,  AKR mice,  and rabbits were compared 
for their ability to enhance the response of NMRI mice to 4 X  105 SRC. The 
three preparations were obtained from sera taken 5 days after a large dose of 
SRC, and the amounts injected into the NMRI mice corresponded in all cases 
TABLE II 
Comparison of the Enhancing Effect of Specific 19S Antibody in Homologous 
and Heterologous Euglobulins 
Source of euglobullu 
None (control) 
NMRI mice 
AKR mice 
Rabbits 
PFC response  per spleen  of ~  mice 
4,000 
31,500 
19,000 
10,300 
Each mouse of three groups of 20 NMRI mice received 0.t  mi i.v. of a  19S  antibody 
preparation of hemolytic titer 5120, followed 1 hr later by 4  X  105 SRC. A fourth group 
served as controls. PFC per spleen were determined 6 days later. 
to 0.1 ml of a preparation of hemolytic titer 5120. Each test group contained 
20 animals.  The results are shown in Table II. 
Although  the  passively  administered  heterologous  19S  antibody  is  less 
effective than homologous preparations, it is unquestionably capable of enhanc- 
ing the response.  Species- and strain-specific  properties of IgM seem to be of 
some consequence but not decisive for its enhancing capacity. 
Purity of the  19S  Preparations.--Contaminating  specific  7S  antibody was 
found in all  19S preparations by the criterium  of indirect plate titration for 
ME-resistant hemolysins.  Our method of indirect titration of 7S antibody gave 
values 300-fold higher than those obtained in direct titrafions. Assuming that 
direct 7S hemolytic titers must be multiplied by 1000 for molar comparison 
with 19S hemolytic titers, we have multiplied the indirect ME-resistant titers 
by 10/3. On this presumed molar basis, we have estimated that about 5 % of 
the  specific  antibody molecules  in  the density gradient  preparations  of  19S 
were 7S antibody whereas most euglobulin  preparations  and the preparation 146  REGULATION O~  PRIMARY IMMUNE RESPONSE 
obtained by electrophoresis +  Sephadex G-200 showed 15-25 % contamination 
with specific 7S  globulin.  This degree of contamination has been ignored  (as 
was done in Table III) because of the low avidity of the contaminating early 
7S  antibody.  Several workers have shown that  7S  antibody of low avidity is 
less suppressive than more avid antibody.  In agreement with  these findings, 
TABLE III 
Responses of Mice Injected with 19S and 7S Antlbodies, and Mixtures Thereof, 
Prior to 4  X  10  5 SRC 
Hemolytic titer of 
19S antibody 
preparation  (.4) 
7680 
3840 
1920 
960 
7680 
3840 
384O 
3840 
3840 
1920 
1920 
960 
96O 
Hemolytic titer of 
7S antibody 
preparation (B) 
9.6 
4.8 
2.4 
1.2 
0.6 
0.3 
9.6 
4.8 
2.4 
1.2 
0.6 
1.2 
0.6 
1.2 
0.6 
Total  PFC  per spleen 
Observed 
3,600 
54,000 
37,000 
16,800 
10,500 
92 
160 
242 
450 
1,125 
1,150 
1,500 
2,400 
6,600 
13,400 
14,000 
8,000 
9,400 
1,400 
6,400 
Calculated* 
4,000 
35,000 
29,500 
22,500 
16,000 
90 
170 
330 
620 
1,100 
1,700 
3,250 
3,300 
6,000 
10,060 
14,500 
5,800 
9,200 
3,600 
5,600 
* See Appendix. 
The figures in the first two columns represent the direct hemolytic titers of the antibody 
preparations injected. The amount of each preparation injected was 0.1 ml in all cases. The 
first seven groups contained 20 mice each, the remainder contained 10 each. The responses 
were determined 6 days after the injection of SRC's. 
we have found that the enhancing capability of  our  euglobulin  preparations 
can be reduced  by the  addition  of an  amount  of hyperimmune  7S  antibody 
which  is many times  lower  than  that  of  the  low  avidity early  7S  antibody 
already  present  in  the  19S  preparation.  The  contaminating  low  avidity  7S 
antibody is perceptibly depressive, however, when the level of contamination 
exceeds about 20%.  Two euglobulin  preparations,  which  showed about 50% 
contamination with  specific early 7S  antibody,  were only half as effective in CLAUDIA HENRY AND NIELS K. ~EI~N'E  147 
enhancing the response to 4 X  10  5 SRC as would be predicted on the basis of 
their 19S hemolytic titers. The effect of these two preparations is represented 
by the two encircled points which lie significantly beneath the 19S curve in 
Fig.  3.  Repeated precipitation  in  aqueous  solution at pH  5.5  yielded 19S 
antibody preparations of greater purity but resulted in considerable  loss of 
macroglobulin.  The  contamination  of  our  19S  preparations  with  specific 
"7S" antibody was  calculated above  on the basis  of determinations of the 
presence  of ME-resistant hemolytic antibody. The degree  of contamination 
seems quite high and probably does not represent a  contamination with 7S 
molecules but with polymerized  IgG molecules. 
Experiments with Mixtures of 19S and 75; Antibodies 
When mixtures of 19S  and 7S  antibodies  are injected prior  to SRC,  the 
response is intermediate between the enhanced value and the depressed value 
observed  when either  type of preparation is  given  alone.  Groups  of  10-20 
NMRI mice received 4 X  105 SRC intravenously, preceded  1-2 hr earlier by 
an intravenous injection of 0.1  ml of a  19S  antibody preparation,  or  a  7S 
antibody preparation,  or a  mixture of the two.  In the first two columns  of 
Table III, the 195 hemolytic titer (A) and the direct 7S hemolytic titer (B) of 
the antibody injected is given. The third column of this table shows the number 
of PFC per spleen determined 6 days later. For example, it is seen that an 
almost normal response level is obtained when a  19S antibody preparation of 
hemolytic titer  3840 is  given  together  with  a  7S  antibody preparation  of 
direct hemolytic titer 4.8. We have tentatively explored  a model for this 7S 
versus 19S antagonism. The model, which is described in the Appendix to this 
paper, is based on a competition of 7S and 19S antibody molecules for available 
sites on the SRC surface and proposes that only antigenic determinants that 
are covered by a 19S antibody molecule can stimulate a target lymphocyte. 
DISCUSSION 
The present  experiments  contribute to a  subject that is  coming into the 
focus of attention in immunology: the question of the multiplicity of antigen 
receptors. It has been clear for a long time (27) that, before the events leading 
to antibody formation can be initiated, the antigen must be recognized as an 
immunogenic  particle.  To this end,  antigen receptors  must be available  and 
these must exhibit antibody-combining sites.  Plainly speaking,  they must be 
antibody molecules.  One  type of  antigen receptors  may be  situated on the 
target lymphocytes. The experiments on blast transformation of small lympho- 
cytes by Sell and Gell (28), as well as those on allotypic suppression by Dubiski 
and Fradette (29), Mage and Dray (30) offer evidence for the existance of such 
lymphocytic receptors which have properties  in common with immunoglobulin 
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antibody and to proliferate by a direct encounter of circulating antigen with 
the antigen receptors of this cell. The mechanism appears to be more complex, 
however. The experiments of Mitchison (31),  Benacerraf (32),  Rajewsky and 
Rottl~nder (33),  and others appear to have established the fact that irnrnuno- 
genicity of an antigenic particle involves at least two properties:  a  "carrier" 
property and a  "hapten" property. It would seem that unless carrier sites on 
the  antigen are  recognized by an  early antigen receptor,  the  haptenic sites 
cannot trigger the final antigen receptor of the target lymphocyte. In order to 
resolve these questions we need to clarify the  number  of  different types  of 
antigen receptors, as well as their function. An obvious class of antigen receptors 
which participate in the events leading to an immune response, or which can 
intervene in these events,  are the circulating antibody molecules themselves, 
both those that may have arisen spontaneously as "natural" antibodies and 
those that owe their existence to a previous antigenic stimulus. It is therefore 
necessary to investigate the effect of antibodies of all immunoglobulin classes 
in the primary and secondary immune response. 
The results presented in the present paper show that the feedback effect of 
antibodies on the primary immune response is not always negative. We have 
confirmed that the specific  antibody contained in 7S fractions suppresses the 
primary immune response. We have demonstrated that the antibody contained 
in  19S  fractions enhances  the primary response  of mice  to  SRC.  Our  most 
concentrated preparations of 19S  antibody, when given prior  to a  moderate 
dose of SRC, increased the response 10- to 15-fold. 
Contrary findings by others that 19S antibody is suppressive may perhaps 
be explained by a  contamination of 19S  preparations by 7S  antibody. With 
current methods of fractionation it is difficult to obtain sizable quantities of 
pure 19S immunoglobulin. As 7S antibody is an inefficient hemolytic antibody 
compared to 19S  antibody, a  considerable contamination on a molar scale of 
comparison may go unnoticed. Furthermore, as we have shown that the degree 
of  depression  increases  more  rapidly  with  increasing  concentrations  of  7S 
antibody than the degree of enhancement rises with increasing concentrations 
of  19S  antibody,  contaminating 7S  antibody will be  less  effective in  small 
doses of contaminated preparations, but may dominate in larger doses. 
In our experiments with specific 7S antibody, we have focussed attention on 
the fact that even very low concentrations of 7S antibody suffice for a marked 
suppression  of  the  primary response.  Depression  is  more  pronounced  when 
more time is allowed between the injection of 7S antibody and the injection of 
the antigen. It is reasonable to believe that the depressive effect operates also 
in  the  normal  response  when  7S  antibodies  of sufficient avidity make  their 
appearance. The enhancing effect of 19S antibodies likewise must be assumed 
to play a  role in the normal response, since 19S antibodies are the first to be 
produced and, moreover, can be demonstrated prior to the antigenic stimulus 
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In reviewing our experimental results, it seems striking that in many cases 
there is a time span between the injection of antibody and the first signs of an 
effect. Thus 7S antibody in several of our experiments, as well as in those of 
Mt~ller and Wigzell (7) and Wigzeil (10) fails to manifest its effect until 24-48 
hr after injection. Likewise, the presence of 19S antibody does not markedly 
affect the number of PFC arising in the early phase after an antigenic stimulus, 
but manifests its effect after the 3rd day. 
It is important to note that antibodies harvested from one animal species 
are active in a different anlrnal species, as this suggests that the mechanism by 
which the antibody acts is not at a genetic or synthetic level but rather involves 
the  reaction of antibody-combining sites with  the  antigen and perhaps  also 
the cytophilic properties of the antibody molecules. It is most simple to imagine 
that the suppressive effect of 7S antibody molecules results from coverage of 
antigenic  determinants  which  are  thus  prevented from participating  in  the 
immunogenic stimulus.  It  is more  difficult to  suggest  a  mechanism  for en- 
hancement by  19S  antibody.  A  possibility  that  comes  to mind  is  that  19S 
molecules,  attached  cytophilically to  macrophage  membranes,  may  capture 
antigenic  particles  by  combining  with  antigenic  determinants  and  thereby 
offer  other  antigenic  determinants  that  have  remained  free  to  the  target 
lymphocytes. 
It remains to be seen whether antibody molecules of certain Ig classes are 
necessary components of the primary immune stimulus,  and  to what extent 
other Ig classes of antibody can interfere. 
SUMMARY 
Prior to sheep red cells (SRC) mice were given 7S or 19S anti-SRC antibodies 
or mixtures of both. All 7S preparations suppressed the immune response. All 
19S  preparations  enhanced  the primary response,  as measured by an up  to 
15-fold increase in the number of PFC per spleen. Results obtained with mix- 
tures showed that 7S and 19S antibodies are competitive in their effect. The 
kinetics of the appearance of PFC in the mouse spleen after injection of SRC 
suggest that the depressive effect of 7S antibody simulates a reduction in SRC 
dose, whereas the enhancing effect of 19S  antibody  appears  as  a  temporary 
increase in the rate at which PFC appear. Antibodies from one animal species 
are quite effective in another species. 
We thank Mrs. L. Brzoska for her excellent  technical assistance, Dr. L. Hiibner for doing 
the Lowry protein estimations, and Dr. P. Kaiser for the 19S sample prepared by block elec- 
trophoresis and Sephadex filtration. This research project was supported by a grant No. Ai 
07606 from the United States Public Health Service. 
BIBLIOGRAPHY 
1.  Jerne, N. K.  1955. The natural selection  theory of antibody formation. Proc. 
Natl. Acad. Sci. U.S. 41:849. 150  REGULATION OF  PRIMARY IMMUNE RESPONSE 
2.  Boyden, S. V. 1960. Antibody production. Nature. 185:724. 
3.  Eisen,  H. N., and F. Karush. 1964. Immune tolerance and an extracellular regu- 
latory role for bivalent antibody. Nature. 202:677. 
4.  Rowley, D. A., and F. W. Fitch. 1964. Homeostasis of antibody formation in the 
adult rat. J. Exptl. Med. 120:987. 
5.  Uhr, J. W., and J. B. Baumann.  1961. Antibody formation. I. The suppression 
of  antibody  formation by passively administered  antibody.  J.  Exptl.  Med. 
113:935. 
6.  Finkelstein, M. S., and J. W. Uhr. 1964. Specific inhibition of antibody formation 
by passively administered 19S and 7S antibody. Science. 146:67. 
7.  M611er, G., and H. Wigzell.  1965. Antibody synthesis at the cellular level.  Anti- 
body-induced suppression of 19S and 7S response.  J. Exptl. Meg. 121:969. 
8.  Sahiar, K., and R. M. Schwartz. 1964. Inhibition of 19S antibody synthesis by 7S 
antibody. Science. 145:395. 
9.  Dixon, F.  J., H. Jacot-Guillarmod, and  P.  J. McConahey.  1967. The effect of 
passively administered antibody on antibody synthesis. J. Exptt. Med. 19-5:1119. 
10.  Wigzell,  H.  1966. Antibody-induced  suppression  of  7S  antibody  synthesis.  J. 
Exptl. Med. 124:953. 
11.  Brody, N. I., S.  G. Walker, and G. W. Siskind.  1967. Studies  on the control of 
antibody synthesis. J. Exptt. Med. 196:81. 
12.  Segre, D., and M. L. Kaeberle. 1962. The immunologic  behaviour of baby pigs. 
I. Production of antibody in three week old pigs. J. Immunol. 89:782. 
13.  Hemphlll, F. E., D. Segre, and W. L. Myers. 1966. Termination of immunologic 
tolerance in mice by antigen-antibody complexes. Proc. Soc. Exptl. Biol.  Med. 
123:265. 
14.  Williams,  G. M.  1966. Antigen localization  in lymphopenic states. Immunology. 
11:467 and 475. 
15.  Pearlman, D. S. 1967. The influence of antibodies on immunologic responses.  The 
effect  on  the  response to  particulate  antigen  in  the  rabbit.  Y.  Exptl.  Meal. 
19.6:127. 
16.  Clarke,  C. A., W. T. A. Donohue, R. B. McConnell,  J.  C. Woodrow,  R. Finn, 
J. R. Krevans, W. W. Kulke, D. Lehane, and P. M. Sheppard. 1963. Further 
experimental studies on the prevention of Rh haemolytic disease. Brit. Med. J, 
1:979. 
17.  Henry, C., and N. K. Jerne. 1967. The depressive effect of 7S antibody and the 
enhancing  effect  of  19S  antibody  in  the  regulation  of the  primary immune 
response.  In Nobel Symposium Three, Gamma Globulins. J. Killander, editor. 
Almqvist and Wiksell,  Stockholm.  421. 
18.  Jerne, N. K., A. A. Nordin, and C. Henry. 1963. The agar plaque technique for 
recognizing  antibody-producing cells. In Cell Bound Antibodies.  B. Amos and 
H. Koprowski, editors.  Wistar Institute Press, Philadelphia. 109. 
19.  Jerne, N. K., A. A. Nordin, C. Henry, H. Fuji, and A. M. C. Koros. 1968. Methods 
in Immunology. C. A. Williams and M. W. Chase, editors, Academic Press Inc., 
N.Y. 2. In press. 
20.  Humphrey, J. H., and R. R. Dourmaskin. 1965. Electron microscope studies of 
immune cell tysis.  Ciba Found.  Syrup.  Complement. 175. CLAIYDIA HENRY AND NIELS K.  JERNE  151 
21.  Humphrey, J. H.  1967. The haemolytic effidency of rabbit IgG anti-Forssman 
antibody and its augmentation by anti-rabbit IgG. Nature. 216:1295. 
22.  Fahey, J. L., J. Wunderlich, and R. Mishell. 1964. The immunoglobulins of mice. 
I.  Four major  classes  of immunoglobulins:  7S  ~,~_, 7S  ~'1-,  ~/~, (fl~A), and 
18S 3'~M-globuhns. J. Exptl. Med. 120:223. 
23.  Lowry, O. H., N. J.  Rosebrough, A. L. Larr, and R. J. Randall.  1951. Protein 
measurement with the folin phenol reagent. J. Biol. Chem. 193:256. 
24.  Kendall,  D.  G.  1948.  On some modes of population growth leading  to R.  A. 
Fisher's logarithmic series distribution. Biometrika 35:6. 
25.  Simid, M. M., V. S.  ~ljivid, M.Z. Petrovi~, and D. M.  (~irkovi6. 1965. Antibody 
formation in  irradiated  rats.  Bull.  Boris  Kidri~  Inst. Nucl.  Sci.  (Belgrade). 
16(Suppl. 1) :1. 
26.  Schultze, H. E. and J. F. Heremans. 1966. Molecular Biology of Human Proteins. 
Elsevier Publishing Co., Amsterdam, 1:273. 
27.  Jerne, N. K. 1960. Immunological speculations. Ann. Roy. Microbiol. 14:341. 
28.  Sell, S. and P. G. H. Gell. 1965. Studies on rabbit lymphocytes in vitro. I. Stimu- 
lation of blast formation with an anti-allotype serum. J. Exptl. Meal. 122:423. 
29.  Dubiski, S. and K. Fradette. 1966. The feed-back mechanism in immunoglohulin 
synthesis. Proc. Soc. Exptl. Biol. Med. 132:126. 
30.  Mage, R. and S. Dray.  1965. Persistent  altered phenotypic expression of allelic 
7G-immunoglobulin allotypes in heterozygons rabbits exposed to isoantibodies 
in fetal and neonatal life. J. Immunol. 95:525. 
31. Mitchison, N. A. 1967. Antigen recognition responsible for the induction in vitro 
of the secondary response. Cold Spring Harbor Syrup. Quant. Biol. 32:431. 
32.  Benacerraf, B., I. Green, and W. E. Paul. 1967. The immune response of guinea 
pigs to hapten-poly-r-lysine conjugates as an example of the genetic control of 
the recognition of antigenicity. Cold Spring Harbor Syrup. Quant. Biol. 32:569. 
33.  Rajewsky, K.  and  E. Rottl~tnder.  1967.  Tolerance specificity and  the immune 
response  to  lactic  dehydrogenase  isoenzymes.  Cold  Spring  Harbor  Syrup. 
Quant.  Biol. 32:547. 
34.  Hughes-Jones, N. C., B. Gardner,  and R. Jelford.  1963. Studies  on the reaction 
between blood-group antibody anti-D and erythrocytes. Biochem. J. 88:435. 
APPENDIX 
A model, suggested by Dr. D. Kodlin, assumes that the maximal yield of antibody-forming 
cells (measured as PFC) after the injection of a given number of SRC is proportional to the 
average number of 19S antibody molecules attached to a SRC. Specific 7S and 19S antibody 
molecules compete for sites on the SRC, and the depressive action of 7S antibody is explained 
by the reduction of the fraction of sites that remain occupied by 19S molecules. 
Assuming the reversible equilibrium 
site +  antibody molecule ~  occupied site 
it can be shown that the fraction F of sites to which 19S antibody molecules are attached  is 
K=a 
F= 
1 +  Kaa +  K~b 152  REGULATION  O:F  PRIMARY  I~fM'UN'E RESPONSE 
in which Ka and Kb are the association constants of the 19S and 7S antibody with SRC deter- 
minants, and a  and b the molar concentrations of 19S and 7S antibody. Considering that in 
normal mice a small concentration of 19S hemolytic antibody, but not of 7S antibody, can be 
detected, the following parameters were adopted: 
Ka --  109 ~-1 
Kb = 101° x~--i 
a=  10  -1°+0.05X  10  -11XAM 
bf0.05X  10  -sXB 
where A and B stand for the direct hemolytic titers of the 19S and 7S antibody administered 
in a 0.1 mi volume. The association constants adopted lie within the range found for human 
blood group antibodies (34). The factor 0.05 reflects the dilution of 0.1 ml into the blood of a 
mouse.  The lowest concentrations detectable by direct hemolytic tests are assumed  to  be 
10  -s ~  for IgG and 10  -u M for IgM. 
Using these parameters, the formula shows that in normal mice F0  ffi 0.09, i.e. that on the 
average 9% of the sites of injected SRC become occupied by 19S antibody molecules. As nor- 
mal mice show an average response to 4  X  10  ~ SRC of 4000 PFC per spleen 6 days after the 
SRC injection, it is postulated that antibody-treated mice will show an average response of 
F/Fo  X  4000 PFC. 
In Table III the hemolytic titers A and B of the antibody mixture injected have been listed, 
as well as the response values calculated by this model. It is seen that these agree satisfactorily 
with the experimental results. This agreement may be merely accidental, however, and the 
model does not account for the apparent differences in mode of action of 19S and 7S antibodies, 
that we have described. 
A relationship of the same type as given by the above formula would result from a model 
which assumes that the response is directly proportional both to the concentration a of specific 
IgM and to the fraction 1/for antigenic determinants remaining free of antibody attachment 
(.f ffi  1  +  Kc, a  +  Kbb). 